PlasmidFactory
Private Company
Funding information not available
Overview
PlasmidFactory is a well-established, privately-held German CDMO with over 25 years of experience in nucleic acid manufacturing. It has carved a niche as a specialist in plasmid and, notably, its proprietary minicircle DNA technology, serving the burgeoning cell and gene therapy markets. The company operates a service-based business model, generating revenue by producing high-purity DNA starting materials for clients worldwide, from research to commercial GMP supply. Its value proposition centers on technical expertise in difficult-to-produce constructs, antibiotic-free fermentation, and guaranteed batch yields.
Technology Platform
Proprietary plasmid and minicircle DNA manufacturing platform, featuring antibiotic-free fermentation, scalable GMP production up to 10g/run, and bespoke technology for difficult constructs (e.g., ITRAAV, PolyA120) and minicircle DNA for AAV and CAR-T applications.
Opportunities
Risk Factors
Competitive Landscape
PlasmidFactory competes with other specialized plasmid DNA CDMOs (e.g., VGXI, Aldevron, LakePharma) and the in-house manufacturing capabilities of large biopharma. Its differentiation lies in its deep focus on plasmids/minicircles, proprietary technology for difficult sequences, antibiotic-free production, and a 25-year track record in this specific niche.